Biolife Solutions Cash Flow Statement (2010-2025) | BLFS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-1.12M	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-4.68M	-13.33M	-32.84M	-7.02M	-15.16M	-1.18M	11.98M				7.54M
Depreciation and Depletion (Quarter)	0.57M	0.82M	0.69M	0.80M	0.76M	0.70M	0.90M	-1.60M	0.90M	0.80M	1.00M	-2.20M	0.20M	0.20M	0.20M	0.10M	0.20M	0.20M	0.20M	0.10M
Share-based Compensation (Quarter)	2.52M	2.10M	4.87M	5.07M	5.40M		6.30M	7.66M	7.36M	6.86M	9.12M	9.91M	6.18M	8.72M	5.33M	10.69M	4.15M	5.86M	5.90M	7.08M
Deferred Taxes (Quarter)		-12.55M	-4.99M	-2.59M	-0.60M	-3.74M	-0.60M	-0.30M	0.01M		0.02M	-0.10M	0.01M		-0.09M	0.02M	0.01M	0.04M	0.01M
Gains from Sales and Divestitures (Quarter)	0.23M	0.13M	0.24M	0.23M	0.17M	0.22M	0.45M	0.22M	0.35M
Gains from Investment Securities (Quarter)		1.80M	-0.14M	-1.57M	-3.33M	-2.36M	2.35M	2.60M	0.72M	-0.92M	-1.58M	-1.97M	0.01M			3.92M			0.04M	0.94M
Asset Writedowns and Impairment (Quarter)						69.90M		-69.90M			8.31M
Non-cash Items (Quarter)	24.50M	17.10M	0.67M	0.62M	0.49M	5.50M	9.40M	7.30M	7.30M
Cash from Operations (Quarter)	1.82M	-7.72M	2.08M	-0.77M	-7.92M	-9.92M	1.50M	7.86M	-2.71M	-7.72M	-4.38M	2.31M	-4.47M	6.46M	4.80M	1.65M	1.73M	7.37M	6.10M	4.92M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.93M	1.88M	2.52M	2.90M	2.86M	2.90M	2.50M	-4.21M	1.46M	1.40M	1.31M	-3.10M	0.70M	0.68M	0.68M	-1.63M	0.70M	0.71M	0.70M	-0.27M
Amortization of Deferred Charges (Quarter)								0.02M	0.01M
Depreciation & Amortization (CF) (Quarter)	0.78M	1.12M	1.14M	1.63M	1.65M	1.60M	1.80M	1.72M	1.72M	2.00M	1.92M	1.47M	1.36M	1.45M	1.41M	0.94M	0.68M	0.67M	0.64M	0.26M
Change in Working Capital
Change in Receivables (Quarter)	2.66M	5.83M	-1.35M	2.99M	1.08M	7.04M	1.31M	1.31M	-3.61M	-3.48M	-2.35M	-5.91M	-0.07M	1.94M	-0.21M	1.23M	-0.00M	0.89M	0.78M	-1.94M
Change in Inventory (Quarter)	0.07M	-1.35M	2.52M	-1.35M	1.85M	3.13M	0.41M	1.16M	6.42M	-2.15M	4.18M	0.10M	-0.04M	-1.76M	-0.32M	1.34M	-1.45M	0.19M	0.20M	2.33M
Change in Account Payables (Quarter)	0.60M	-3.39M	4.16M	0.65M	-3.23M	-0.17M	-0.21M	4.03M	0.16M	-4.84M	1.30M	-5.04M	-1.96M	1.19M	-0.37M	1.17M	-0.83M	0.37M	-0.68M	-0.95M
Change in Accured Expenses (Quarter)	1.69M	-2.37M	-1.85M	2.30M			0.44M	-0.70M	-0.02M	0.04M	-1.72M	1.79M	-2.83M	2.56M	-0.31M	0.32M	0.02M	-3.40M	3.39M	0.26M
Change in Taxes (Quarter)					1.54M	0.06M	-0.07M		0.51M	0.41M	0.41M	-0.02M	0.02M	-0.41M	-0.50M	-0.08M	-0.33M	-0.30M	0.10M	-1.39M
Other Working Capital Changes (Quarter)	0.00M	0.04M	0.04M	-0.15M	-0.02M	0.22M	0.10M	-0.14M	-0.05M	-0.00M	0.05M
Investing Activities
Capital Expenditures (Quarter)	1.72M	-1.72M	6.82M	1.57M	1.46M	-1.35M	1.56M	-1.18M	3.29M	-2.46M	3.23M	2.32M	0.36M	-0.05M	-0.20M	0.01M	0.55M	-0.46M	5.13M	4.26M
Sales of Property, Plant and Equipment (Quarter)	0.00M	-0.00M	0.02M	-0.02M
Acquisitions (Quarter)			1.52M
Change in Acquisitions & Divestments (Quarter)								-0.33M	0.52M	1.33M	1.12M	0.50M	0.97M	0.82M	0.82M	0.91M	0.57M	1.18M	1.84M	3.24M
Cash from Investing Activities (Quarter)	-4.43M	-4.22M	-2.01M	-2.54M	-2.27M	-25.07M	-15.88M	-14.89M	2.93M	9.29M	1.66M	3.96M	-0.22M	-13.44M	-1.68M	73.64M	-27.18M	-39.53M	-5.97M	1.14M
Financing Activities
Other financing activities (Quarter)	-0.08M	0.08M	0.14M		0.04M	-0.03M	0.12M	0.00M	0.01M	-0.03M	0.09M	-0.01M	0.02M	-0.05M	0.02M	-0.06M	0.01M	0.01M	0.01M	0.00M
Cash from Financing Activities (Quarter)	1.22M	-0.83M	-1.06M	-2.10M	-0.18M	-0.29M	17.41M	-0.62M	-0.56M	0.70M	0.61M	9.84M	-0.95M	-0.70M	-1.04M	-4.09M	-2.99M	-2.88M	-2.56M	-2.50M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)		0.00M	-0.17M	0.14M	-0.02M	-0.17M	0.01M	0.07M	0.01M	0.02M	-0.06M	0.06M	-0.07M		0.04M	0.03M
Change in Cash (Quarter)	-1.39M	-12.77M	-0.98M	-5.42M	-10.38M	-35.28M	3.02M	-7.66M	-0.35M	2.28M	-2.11M	16.11M	-5.65M	-7.68M	2.08M	71.20M	-28.44M	-35.04M	-2.42M	3.56M
Free Cash Flow (Quarter)	0.10M	-6.00M	-4.74M	-2.34M	-9.38M	-8.56M	-0.06M	9.04M	-6.01M	-5.25M	-7.61M	-0.01M	-4.83M	6.51M	5.01M	1.64M	1.18M	7.83M	0.97M	0.66M
Net Cash Flow (Quarter)	-1.39M	-12.77M	-0.98M	-5.42M	-10.38M	-35.28M	3.02M	-7.66M	-0.35M	2.28M	-2.11M	16.11M	-5.65M	-7.68M	2.08M	71.20M	-28.44M	-35.04M	-2.42M	3.56M

Research Tools

Biolife Solutions Cash Flow Statement (2010-2025) | BLFS

Create an account

Sign In

Reset Password